Search

everythinglearnresearchcommunity

for

Search:↓

High doses of finasteride cause cell growth and tumors in mice.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

A man had a benign pilar cyst on his face, which is rare and was successfully removed by surgery.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

A rare ovarian tumor caused high testosterone, hair loss, and missed periods, but surgery fixed these issues and led to pregnancy.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Inactive hair follicle stem cells help prevent skin cancer.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Finasteride does not prevent bladder cancer.

Finasteride helped treat a 28-year-old's facial skin condition.